Back

prof. dr. M.C. Post

Full Professor

  • Division of Heart & Lungs

  1. Contact
  2. Research Programs
  3. Research Output

Contact

E

Research Programs

Research Output (162)

New developments in adult congenital heart disease

Bouma B. J., Sieswerda G. T., Post M. C., Ebels T., van Kimmenade R., de Winter R. J., Mulder B. J. 1 aug 2020, In: Netherlands Heart Journal. 28 , p. 44-49 6 p.

Prevalence and diagnostic value of nail fold capillary microscopy in hereditary hemorrhagic telangiectasia:A retrospective study

Kroon Steven, Vorselaars Veronique M.M., Hosman Anna E., Post Martijn C., Snijder Repke J., Mager Johannes J. 1 aug 2020, In: Vascular Medicine (United Kingdom). 25 , p. 341-347 7 p.

Does combination therapy work in chronic thromboembolic pulmonary hypertension?

van Thor M. C.J., Snijder R. J., Kelder J. C., Mager J. J., Post M. C. aug 2020, In: IJC Heart and Vasculature. 29 6 p.

Long-term real world clinical outcomes of macitentan therapy in chronic thromboembolic pulmonary hypertension

van Thor M. C.J., ten Klooster L., Snijder R. J., Mager J. J., Post M. C. jun 2020, In: Respiratory Medicine. 167

Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the Netherlands

van Thor M. C.J., Lely R. J., Braams N. J., ten Klooster L., Beijk M. A.M., Heijmen R. H., van den Heuvel D. A.F., Rensing B. J.W.M., Snijder R. J., Vonk Noordegraaf A., Nossent E. J., Meijboom L. J., Symersky P., Mager J. J., Bogaard H. J., Post M. C. 1 feb 2020, In: Netherlands Heart Journal. 28 , p. 81-88 8 p.

Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults:More than 800 Patient-Years of Follow-Up

Snijder R. J.R., Renes L. E., Bosshardt D., Suttorp M. J., Ten Berg J. M., Post M. C. 1 jan 2020, In: Journal of Interventional Cardiology. 2020 , p. 7136802

A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure:Design and rationale of the MONITOR HF multicentre randomised clinical trial

Brugts J. J., Veenis J. F., Radhoe S. P., Linssen G. C.M., van Gent M., Borleffs C. J.W., van Ramshorst J., van Pol P., Tukkie R., Spee R. F., Emans M. E., Kok W., van Halm V., Handoko L., Beeres S. L.M.A., Post M. C., Boersma E., Lenzen M. J., Manintveld O. C., Koffijberg H., van Baal P., Versteegh M., Smilde T. D., van Heerebeek L., Rienstra M., Mosterd A., Delnoy P. P.H., Asselbergs F. W., Brunner-La Rocca H. P., de Boer R. A. 1 jan 2020, In: Netherlands Heart Journal. 28 , p. 16-26 11 p.

Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial)

Hanff Thomas C., Kaye David M., Hayward Christopher S., Post Martijn C., Malek Filip, Hasenfuβ Gerd, Gustafsson Finn, Burkhoff Daniel, Shah Sanjiv J., Litwin Sheldon E., Kahwash Rami, Hummel Scott L., Borlaug Barry A., Solomon Scott D., Lam Carolyn S.P., Komtebedde Jan, Silvestry Frank E., 15 dec 2019, In: American Journal of Cardiology. 124 , p. 1912-1917 6 p.

Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?

van Thor M. C.J., ten Klooster L., Snijder R. J., Kelder J. C., Mager J. J., Post M. C. 1 dec 2019, In: Lung. 197 , p. 753-760 8 p.

Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation

Wintgens L. I.S., Vorselaars V. M.M., Klaver M. N., Swaans M. J., Alipour A., Rensing B. J.W.M., Post M. C., Boersma L. V.A. 1 dec 2019, In: Netherlands Heart Journal. 27 , p. 613-620 8 p.

All Research Output (162)